NEW YORK, Sept. 26, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets http://www.reportlinker.com/p01636157/2014-Opportunities-in-the-US-Clinical-Chemistry-and-Immunodiagnostics-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

"2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets" is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Strategic Recommendations

- New product development opportunitieswith significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborativearrangements and new products in R&D.

- The companies analyzed in the report includeAbbott, AdnaGen, Agilent, Alere, Beckman Coulter/Danaher, Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin, Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex, Ortho-Clinical Diagnotics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE.

Tests Analyzed in the Report:

- Routine Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

- Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

- Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.

- Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.

- Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.

- Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.

Market Segmentation Analysis

- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.

- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:

- Hospitals- Commercial/Private Laboratories- Physician Offices/Group Practices

Current and Emerging Products

- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging technologies, and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Contains 600 pages and 120 tables

I. Introduction

II. Major Product Development Opportunities

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

A. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation

V. Potential Market Entry Barriers and Risks

A. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market Challenges

VI. Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests1. Albumin2. Alkaline Phosphatase3. ALT/SGPT4. Ammonia5. Amylase6. AST/SGOT7. Bilirubin, Total8. Blood Gases9. Blood Urea Nitrogen (BUN)10. Calcium11. Cardio CRP12. Cholesterol13. Cholinesterase14. CRP15. Creatinine 16. Electrolytesa. Carbon Dioxide/Bicarbonateb. Chloridec. Potassiumd. Sodium17. Ferritin18. Fructosamine

19. Gamma-Glutamyl Transpeptidase (GGT)20. Glucose21. High Density Lipoprotein (HDL)22. Homocysteine23. Iron24. Lactate Dehydrogenase (LDH)25. Magnesium26. Phosphorus27. Protein28. Triglycerides29. Uric Acid30. TroponinB. Therapeutic Drug Monitoring (TDM)1. Overview2. Carbamazepine3. Cyclosporin4. Digoxin5. Everolimus6. Gentamicin7. Lamotrigine/Lamictal8. Levetiracetam9. Lidocaine10. Lithium11. NAPA/Procainamide12. Phenytoin13. Quinidine14. Sirolimus

15. Tacrolimus16. Theophylline17. Topirimate18. Valproic AcidC. Endocrine Function Tests1. Cortisol2. Estradiol3. Follicle-Stimulating Hormone (FSH)4. Gastrin5. Growth Hormone/IGF-16. Human Chorionic Gonadotropin (HCG)7. LH8. Progesterone9. PTH/IO PTH10. Prolactin11. T312. T3 Free13. T3 Uptake14. T4 (Thyroxine) 15. T4 Free16. TBG17. Testosterone18. Thyroglobulin Ab 19. TPO Ab 20. TSHD. Tumor Markers And Special Chemistry Tests1. AFP

2. CA 15-33. CA 19-94. CA 27-295. Carcinoembrionic Antigen (CEA)6. Folate/Folic Acid7. HCG8. 25-Hydroxy Vitamin D2 and D39. Occult Blood10. Prostate-Specific Antigen (PSA)11. Thyroglobulin12. Vitamin B-12E. Immunoprotein Tests1. Complementa. C3b. C42. Free Light Chains3. Immunofixation4. Immunoglobulins (IgA, IgE, IgG, IgM)5. Haptoglobin6. Prealbumin7. Protein ElectrophoresisF. Drugs of Abuse1. Overview2. Test Methodologies3. Amphetamines4. Barbiturates5. Benzodiazepines6. Cannabinoids/Marijuana

7. Cocaine8. Lysergic Acid Diethylamide (LSD)9. Methadone10. Methaqualone11. Opiates12. Phencyclidine13. Tricyclic AntidepressantsG. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzersH. Major In Vitro Diagnostic TechnologiesAnd Their Potential Applications1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Chemiluminescence c. Enzyme Immunoassays (EIA)° Overview° ELISA° EMIT° Electrochemicald. Radioimmunoassays (RIA)e. Immunoprecipitationf. Affinity Chromatography3. Tandem Mass Spec4. IT and Automation5. Dry Chemistry6. Biosensors

VII. U.S.A.

A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major Suppliers'Instrument and Reagent Sales and Market Shares

XIII. Competitive Assessments

- Abbott Laboratories- AdnaGen- Agilent Technologies - Beckman Coulter/Danaher- Biomedical Diagnostics- BioMerieux- Bio-Rad - DiaSorin- Eiken- Fujirebio/Innogenetics- Instrumentation Laboratory- Kyowa Medex- Matritech/Alere- Ortho-Clinical Diagnostics- Quest Diagnostics- Roche- Siemens- Sysmex- Thermo Fisher- Tosoh- Wako- Wallac/PE

List of Tables

Major Companies Developing or MarketingAlbumin TestsMajor Companies Developing or MarketingAlkaline Phosphatase TestsMajor Companies Developing or MarketingALT/SGPT TestsMajor Companies Developing or MarketingAmylase TestsMajor Companies Developing or MarketingAST/SGOT TestsMajor Companies Developing or MarketingBilirubin TestsMajor Companies Developing or MarketingBlood Gas AnalyzersMajor Companies Developing or MarketingBUN TestsMajor Companies Developing or MarketingCalcium TestsMajor Companies Developing or MarketingCholesterol TestsMajor Companies Developing or MarketingCreatinine TestsMajor Companies Developing or MarketingElectrolyte TestsMajor Companies Developing or MarketingGGT TestsMajor Companies Developing or MarketingGlucose TestsMajor Companies Developing or MarketingHDL Tests Major Companies Developing or MarketingIron TestsMajor Companies Developing or MarketingLDH TestsMajor Companies Developing or MarketingMagnesium TestsMajor Companies Developing or MarketingPhosphorus TestsMajor Companies Developing or MarketingProtein TestsMajor Companies Developing or MarketingTriglycerides TestsMajor Companies Developing or MarketingUric Acid TestsMajor Companies Developing or MarketingTDM TestsMajor Companies Developing or MarketingDigoxin TestsMajor Companies Developing or MarketingLithium TestsMajor Companies Developing or MarketingPhenytoin/Dilantin Tests

Major Companies Developing or MarketingTheophylline TestsMajor Companies Developing or MarketingValproic Acid TestsMajor Companies Developing or MarketingFSH TestsMajor Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingLH TestsMajor Companies Developing or MarketingProlactin TestsMajor Companies Developing or MarketingT3 TestsMajor Companies Developing or MarketingT4 TestsMajor Companies Developing or MarketingTSH TestsMajor Companies Developing or MarketingAFP TestsMajor Companies Developing or MarketingCEA TestsMajor Companies Developing or MarketingFerritin TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingProstatic Acid Phosphatase TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingVitamin B-12/Folate TestsMajor Companies Developing or MarketingCRP TestsMajor Companies Developing or MarketingDrugs of Abuse TestsMajor Companies Developing or MarketingBiosensors for Immunological TestingExecutive Summary Table: U.S.A., Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test CategoryU.S.A., Laboratories Performing Chemistry

and Immunoassay Testing By Market SegmentU.S.A., Hospital Laboratories PerformingChemistry and Immunoassay Tests By Bed SizeU.S.A., Commercial/Private LaboratoriesPerforming Chemistry and Immunoassay TestsBy Annual Test VolumeU.S.A., Total Chemistry and ImmunoassaySpecimen Volume ForecastU.S.A., All Market Segments, Specimen VolumeForecast By Test CategoryU.S.A., Total Clinical Chemistry and ImmunoassayTest Volume Forecast By Test CategoryU.S.A., Routine Chemistry Test VolumeForecast By Market SegmentU.S.A., TDM Test Volume Forecast By Market SegmentU.S.A., Endocrine Function Test VolumeForecast By Market SegmentU.S.A., Drugs of Abuse Test VolumeForecast By Market SegmentU.S.A., Tumor Markers and Special ChemistryTest Volume Forecast By Market SegmentU.S.A., Immunoprotein Test VolumeForecast By Market SegmentU.S.A., All Market Segments, Profiles,Panels and Individual Tests ForecastU.S.A., Hospital Laboratories, Profiles,Panels and Individual Tests ForecastU.S.A., Commercial/Private Laboratories,Profiles, Panels and Individual Tests ForecastU.S.A., Physician Offices/Group Practices,Profiles, Panels and Individual Tests ForecastU.S.A., All Market Segments, RoutineChemistry Test Volume Forecast by AssayU.S.A., Hospital Laboratories, RoutineChemistry Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories,Routine Chemistry Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices,

Routine Chemistry Test Volume Forecast by AssayU.S.A., All Market Segments, TDMTest Volume Forecast by AssayU.S.A., Hospital Laboratories, TDMTest Volume Forecast by AssayU.S.A., Commercial/Private Laboratories,TDM Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices,TDM Test Volume Forecast by AssayU.S.A., All Market Segments, EndocrineFunction Test Volume Forecast by AssayU.S.A., Hospital Laboratories, EndocrineFunction Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories,Endocrine Function Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices,Endocrine Function Test Volume Forecast by AssayU.S.A., All Market Segments, Drugsof Abuse Test Volume Forecast by AssayU.S.A., Hospital Laboratories, Drugsof Abuse Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories,Drugs of Abuse Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices,Drugs of Abuse Test Volume Forecast by AssayU.S.A., All Market Segments, Tumor Markersand Special Chemistry Test Volume Forecast by AssayU.S.A., Hospital Laboratories, Tumor Markersand Special Chemistry Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories,Tumor Markers and Special Chemistry TestVolume Forecast by AssayU.S.A., Physician Offices/Group Practices,Tumor Markers and Special Chemistry TestVolume Forecast by Assay

U.S.A., All Market Segments,Immunoprotein Test Volume Forecast by AssayU.S.A., Hospital Laboratories,Immunoprotein Test Volume Forecast by AssayU.S.A., Commercial/Private Laboratories,Immunoprotein Test Volume Forecast by AssayU.S.A., Physician Offices/Group Practices,Immunoprotein Test Volume Forecast by AssayU.S.A., Total Clinical Chemistry and ImmunoassayReagent Market Forecast By Test CategoryU.S.A., Clinical Chemistry and ImmunoassayCalibrator and Control Market ForecastBy Test CategoryU.S.A., Routine Chemistry Reagent MarketForecast By Market SegmentU.S.A., TDM Reagent Market Forecast By Market SegmentU.S.A., Drugs of Abuse Reagent MarketForecast By Market SegmentU.S.A., Tumor Markers and Special ChemistryReagent Market Forecast By Market SegmentU.S.A., Endocrine Function Reagent MarketForecast By Market Segment U.S.A., All Market Segments, RoutineChemistry Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, RoutineChemistry Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories,Routine Chemistry Reagent Market Forecast by AssayU.S.A., Physician Offices/Group Practices,Routine Chemistry Reagent Market Forecast by AssayU.S.A., All Market Segments, TDMReagent Market Forecast by AssayU.S.A., Hospital Laboratories, TDM

Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories,TDM Reagent Market Forecast by AssayU.S.A., Physician Office/Group Practices,TDM Reagent Market Forecast by AssayU.S.A., All Market Segments, Drugs ofAbuse Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, Drugs ofAbuse Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories,Drugs of Abuse Reagent Market Forecast by AssayU.S.A., Physician Offices/Group Practices,Drugs of Abuse Reagent Market Forecast by AssayU.S.A., All Market Segments, EndocrineFunction Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, EndocrineFunction Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories,Endocrine Function Reagent Market Forecast by AssayU.S.A., Physician Offices/Group Practices,Endocrine Function Reagent Market Forecast by AssayU.S.A., All Market Segments, Tumor Markersand Special Chemistry Reagent Market Forecast by AssayU.S.A., Hospital Laboratories, Tumor Markersand Special Chemistry Reagent Market Forecast by AssayU.S.A., Commercial/Private Laboratories,Tumor Markers and Special Chemistry ReagentMarket Forecast by AssayU.S.A., Physician Offices/Group Practices,Tumor Markers and Special Chemistry ReagentMarket Forecast by AssayU.S.A., All Market Segments,Immunoprotein Reagent Market ForecastU.S.A., Hospital Laboratories,ImmunoproteinReagent Market Forecast ImmunoproteinU.S.A., Commercial/Private Laboratories,Immunoprotein Reagent Market Forecast

U.S.A., Physician Offices/Group Practices,Immunoprotein Reagent Market Forecast by AssayU.S.A., Major Suppliers of Clinical ChemistryReagents, Estimated Sales and Market SharesU.S.A., Major Suppliers of Clinical ChemistryAnalyzers, Estimated Instrument Sales and Market SharesU.S.A., Major Suppliers of Clinical ChemistryDiagnostics Products, Estimated Sales and Market SharesU.S.A., Major Suppliers of ImmunoassayReagents, Estimated Sales and Market SharesU.S.A., Major Suppliers of ImmunoassayAnalyzers, Estimated Instrument Sales and Market SharesU.S.A., Major Suppliers of ImmunoassayDiagnostics Products, Estimated SalesAnd Market SharesU.S.A., Clinical Chemistry and ImmunoassayInstrument Market Forecast By Analyzer Type

To order this report: 2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Marketshttp://www.reportlinker.com/p01636157/2014-Opportunities-in-the-US-Clinical-Chemistry-and-Immunodiagnostics-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________Contact Clare: clare@reportlinker.com US: (339)-368-6001Intl: +1 339-368-6001

SOURCE Reportlinker

RELATED LINKShttp://www.reportlinker.com